STADA Pharmaceuticals

7 articles about STADA Pharmaceuticals

• STADA and Calliditas announce the filing for full marketing authorization of Kinpeygo® in the EU

  9/28/2023

  Partners STADA and Calliditas Therapeutics AB announced the submission of a request to the European Medicines Agency for the Committee for Medicinal Products for Human Use to convert the conditional marketing authorization for Kinpeygo®, their treatment for primary IgA nephropathy, to standard, or "full", marketing authorization.

• 

  Alvotech Unites with Oaktree in $2.25 Billion Merger to Advance Biosimilars

  12/7/2021

  ​Biopharmaceutical firm Alvotech Holdings announced merger plans with Oaktree Acquisition Corp. in a deal that will create a combined entity worth around $2.25 billion.

• Week In Review: Fosun Pharma Eyeing $4 Billion Bid For Germany's STADA Pharmaceuticals

  3/13/2017

• Drugmaker STADA Pharmaceuticals to Launch Rapid Test for Ebola

  2/9/2015

• STADA Pharmaceuticals In Talks With Spirig Pharma Ltd. About Purchase Of Generics Operations

  5/23/2011

• STADA Pharmaceuticals CEO Says Would Not Block a Good Takeover Bid

  3/30/2010

• Germany's STADA Pharmaceuticals Surges on Teva Pharmaceutical Industries Limited Bid Speculation

  8/15/2008